Return to Article Details
THE PREVALENCE AND ASSOCIATED RISK FACTORS OF REBOUND HYPERTHYROIDISM IN GRAVES’ DISEASE AFTER ANTI-THYROID DRUG DOSE REDUCTION (PARAGON STUDY)
Download
Download PDF